Lupin results: Final cohort ( highest dose)

  1. 62 Posts.
    lightbulb Created with Sketch. 383
    I had another look at the results and like very much what I see. I acknowledge and agree with what Pickem said earlier on another thread. I think it likely that the last cohort ( highest dose ) lifted the overall results compared with interim results ( lower dose cohorts) released last year. It has lifted the overall median survival by 2.6 months. If this is the case, the highest dose results, on their own, look very, very good with a median overall survival of around 22 months. Also, we know the doses in this trial are likely sub therapeutic. Double that maximum final dose of 1200mg is being trialled in other trials. This breakdown of the efficacy of different doses will be revealed at the conference.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.8¢
Change
0.000(0.00%)
Mkt cap ! $28.63M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $15.43K 159.9K

Buyers (Bids)

No. Vol. Price($)
1 47773 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 47899 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.